Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Other Non-Current Assets (2018 - 2025)

Historic Other Non-Current Assets for X4 Pharmaceuticals (XFOR) over the last 8 years, with Q3 2025 value amounting to $2.0 million.

  • X4 Pharmaceuticals' Other Non-Current Assets fell 1671.6% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year decrease of 1671.6%. This contributed to the annual value of $2.1 million for FY2024, which is 4484.68% up from last year.
  • X4 Pharmaceuticals' Other Non-Current Assets amounted to $2.0 million in Q3 2025, which was down 1671.6% from $2.4 million recorded in Q2 2025.
  • In the past 5 years, X4 Pharmaceuticals' Other Non-Current Assets ranged from a high of $3.0 million in Q1 2025 and a low of $1.0 million during Q1 2023
  • Its 5-year average for Other Non-Current Assets is $1.8 million, with a median of $1.8 million in 2024.
  • Per our database at Business Quant, X4 Pharmaceuticals' Other Non-Current Assets tumbled by 4711.48% in 2021 and then soared by 10194.37% in 2025.
  • Over the past 5 years, X4 Pharmaceuticals' Other Non-Current Assets (Quarter) stood at $1.7 million in 2021, then dropped by 28.9% to $1.2 million in 2022, then increased by 17.22% to $1.4 million in 2023, then surged by 44.85% to $2.1 million in 2024, then decreased by 5.38% to $2.0 million in 2025.
  • Its Other Non-Current Assets was $2.0 million in Q3 2025, compared to $2.4 million in Q2 2025 and $3.0 million in Q1 2025.